This snapshot brings together the latest information on juvenile arthritis, a relatively uncommon condition affecting less than 1% of Australian children. Limited national statistics make it difficult to evaluate the full extent of the effects of this condition on the children and those who care for them. However, available data show that Australian Government subsidies for new classes of treatment medications have continually increased since their introduction in 2002-03 and hospitalisation rates for girls with juvenile arthritis have increased in the 10 years to 2009-10. The reasons for this latter increase are not yet clear.
ISBN 978-1-74249-393-0; Cat. no. AUS 168; 20pp.; $18
Publication table of contents
- Body section
- Signs and symptoms of juvenile arthritis
- Diagnosis of juvenile arthritis
- Who gets juvenile arthritis?
- Number of children with juvenile arthritis
- How is juvenile arthritis managed?
- What medicines are used to manage juvenile arthritis?
- National statistics on supply of medicines for juvenile arthritis
- How is juvenile arthritis managed in primary health care?
- What role do hospitals play in managing juvenile arthritis?
- How does juvenile arthritis affect quality of life?
- Effects on self-perceived health
- Schooling restrictions
- Effects on family
- End matter
- Appendix 1: Detailed statistical tables
- Related publications
- Verso pages
AIHW 2013. A snapshot of juvenile arthritis. AIHW bulletin no. 113. Cat. no. AUS 168. Canberra: AIHW.